Home
    • Plans Blog Contact
    Core Scientific, Inc./tx logo

    Core Scientific, Inc./tx

    CORZ
    Last price US$20.17
    Market cap US$6.7b
    12M price change 45.79%
    Loading the 12-month Mave Thesis and 1-month news signal

    Industry and sector peers, plus broader research alternatives

    View comparison
    Apple IncAAPL Research alternative Microsoft CorporationMSFT Research alternative NVIDIA CorporationNVDA Research alternative Amazon.com IncAMZN Research alternative
    Overview Earnings Report Price History News Competitors Earnings per Share Return on Equity Net Margin Share Buyback Leverage Financial Statements Financial Ratio
    Dashboard Funda..tals Prediction Screener Map

    Core Scientific, Inc./tx Overview

    Industry: None

    Sector: None

    Read More

    Mavefund brings filings, fundamentals, valuation, price history and news for Core Scientific, Inc./tx into one research view. The sections below show what strengthens or weakens the research case.

    Score

    Reported Results

    What the company reported, with filing details kept small.

    Filed Jul 28, 2026

    Quarterly result summary

    Revenue was $164.2M (+43% YoY). Net loss was -$1. Adjusted EBITDA was $41.1M (+362% YoY).

    Revenue $164.2M +43% YoY
    Net loss -$1 reported
    Adjusted EBITDA $41.1M +362% YoY

    What changed

    • Revenue +43% YoY to $164.2M.
    • Adjusted EBITDA +362% YoY to $41.1M.

    Guidance / outlook

    The Company anticipates that subsequent events and developments will cause the Company’s assessments to change.

    Earnings release Open filing

    Source: SEC EDGAR company-filed earnings materials. Dates are shown only for verification; review the source filing before relying on extracted report details.

    Other recent earnings materials
    SEC filing 10-Q Jul 28, 2026 SEC filing 8-K Jul 28, 2026 Earnings material Earnings release Jul 28, 2026 SEC filing 10-Q May 06, 2026 SEC filing 8-K May 06, 2026 Earnings release Earnings release May 06, 2026 Earnings material Earnings release May 06, 2026 SEC filing 10-K/A Mar 18, 2026 SEC filing 10-Q/A Mar 02, 2026 SEC filing 10-K Mar 02, 2026 SEC filing 10-Q/A Mar 02, 2026

    Prediction-grade evidence

    Recent News

    Company-relevant articles from sources that pass the Mave Signal relevance and reliability checks.

    Earnings Per Share

    Score 3.00/5
    Core Scientific, Inc./tx boasts a high score, as its Earnings Per Share (EPS) has demonstrated consistent growth over the past six years. Notable counterparts in the sector with high scores includes

    Return on Equity

    Score 4.60/5
    Core Scientific, Inc./tx stands out with a superior score in the Return on Equity (ROE) section, surpassing the sector median value and showcasing its strong performance in this metric. The top companies in the same sector include
    Core Scienti... CORZ US$6.7b

    Net Margin

    Score 0.00/5
    Core Scientific, Inc./tx olds a low score as its net margin consistently trails below the sector median value and doesn't exhibit continuous growth over the last six years; notable companies in the sector with commendable scores include
    Core Scienti... CORZ US$6.7b

    Share Buyback

    Leverage

    Score 4.50/5
    Core Scientific, Inc./tx attains a commendable score in the category due to its lower leverage ratio over the past six years in comparison to the sector median value. Additionally, other notable companies in the same sector, such as , also exhibit high scores.
    Core Scienti... CORZ US$6.7b

    Financial Statements

    Company-reported SEC EDGAR facts organized into the three core statements.

    Reported currency
    Verified SEC statements load when this section enters view.

    Source: SEC EDGAR companyfacts. Values are standardized company filings for research support, not personalized financial advice.

    Financial Ratio

    Yearly Quarterly

    Financial
    Profitability
    Growth
    Cash Flow
    Financial Health
    Efficiency Ratios

    Core Scientific, Inc./tx logo

    Core Scientific, Inc./tx

    US$20.17

    US$6.7b

    -3.98%

    45.79%